Cannabis and Menstrual Cramps
Survey data show many users report relief, but no rigorous trials exist. NSAIDs and heat remain first-line.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
Lots of women report that cannabis helps their period pain, and that signal is consistent across multiple countries. But every study is a survey, not a controlled trial. We have no idea if cannabis actually works better than placebo for cramps, what dose does anything, or how it compares head-to-head to ibuprofen or a heating pad. The marketing around vaginal suppositories is pure hype—there's zero evidence they work and no reason to think they'd reach the uterus from the vagina.
Not medical advice
This article is educational, not medical advice. Menstrual pain can signal multiple conditions—endometriosis, adenomyosis, fibroids, pelvic inflammatory disease, ovarian cysts, or other pathology. Severe, worsening, or new-onset pelvic pain requires clinical evaluation, not self-treatment. If you are pregnant or trying to become pregnant, avoid cannabis. Talk to a doctor or pharmacist before substituting cannabis for prescribed treatments, especially hormonal contraceptives or other medications you take.
Plain-language summary
Menstrual cramps (dysmenorrhea) happen because the uterus contracts and restricts blood flow, triggered by prostaglandins—signaling molecules released from the uterine lining during menstruation Strong evidence [1]. First-line treatments (ibuprofen, naproxen, hormonal birth control) work by blocking prostaglandin production or suppressing ovulation Strong evidence [1][2].
Cannabis operates through the endocannabinoid system, which is present in uterine tissue and appears to regulate pain, inflammation, and smooth-muscle contraction Weak / limited [3]. That gives a theoretical reason why cannabis might reduce cramps—but theory is not the same as proof.
The evidence reality: cannabis has been used for period pain in traditional medicine Anecdote. Modern surveys consistently show many users report meaningful relief Weak / limited [4][5], but rigorous randomized controlled trials in humans with menstrual pain are essentially absent. We have no head-to-head data comparing cannabis to NSAIDs, placebo, or heat in this population.
What the research shows
Survey evidence for THC/CBD and menstrual pain.
Multiple survey studies of people with primary dysmenorrhea and endometriosis consistently report that users find cannabis effective for pelvic pain and rate it as equal to or more effective than over-the-counter painkillers Weak / limited [4][5]. An Australian online survey of 484 people with endometriosis asked about self-management strategies; respondents who used cannabis rated it as highly effective for pain reduction, with additional reported benefits for sleep and nausea Weak / limited [5].
However, survey data systematically overestimate real-world effects due to placebo response, recall bias, and selection bias (people for whom cannabis doesn't work are less likely to continue using it or report results). The consistency of the signal across multiple independent surveys and countries is noteworthy but is not a substitute for a controlled trial.
Inhaled THC for acute pain (non-menstrual).
Short-term inhaled THC has substantial evidence of analgesic effect in acute and chronic pain conditions unrelated to menstruation Strong evidence [6]. It is reasonable to expect some crossover to cramp pain, but this is extrapolation, not direct evidence. We don't know the dose, duration of effect, or whether tolerance develops with cyclical use around the menstrual cycle.
CBD alone, oral.
CBD has plausible anti-inflammatory mechanisms Weak / limited, but no published trials exist specifically in menstrual pain. Anecdotal reports suggest some users feel less cramping and inflammation; others report no difference. Because CBD is not psychoactive, it appeals to many, but evidence on dose and effectiveness is absent.
What doesn't have evidence:
- THC/CBD vaginal suppositories. Marketed aggressively for 'targeted' relief, often at premium price, but no published clinical trials show they reduce menstrual pain better than placebo No data. Pharmacokinetic data on vaginal cannabinoid absorption in humans is sparse. Any pain relief may come from the suppository base, local warmth, or systemic absorption indistinguishable from oral ingestion—not from local targeting.
- Topical CBD on the lower abdomen. Cannabinoids are lipophilic but do not penetrate full-thickness skin in concentrations sufficient to reach the uterus No data. Topical CBD may provide modest relief for superficial musculoskeletal pain (tension in lower abdominal muscles) but is not a credible route for deep visceral cramping pain.
- Cannabis to reduce menstrual bleeding. No evidence of benefit No data. THC and CBD are not known anticoagulants or anti-fibrinolytic agents.
- Strain names or terpenes predicting cramp relief. The indica/sativa distinction does not reliably predict effects on pain or muscle relaxation Disputed. Strain name is a poor predictor of cannabinoid and terpene content and therefore effect. See Cannabis Strain Names and Effects for details.
Comparison with standard treatments
NSAIDs (ibuprofen, naproxen, mefenamic acid).
First-line treatment for primary dysmenorrhea. Strong evidence from multiple randomized controlled trials shows they reduce pain in 60–90% of users, with number-needed-to-treat around 2–4 Strong evidence [1][2]. They directly block prostaglandin production. Cheap, widely available, and familiar. Downsides include gastrointestinal upset (especially on an empty stomach); chronic use can strain the kidneys, though short-term cyclical use for menstrual pain is well-tolerated in most people.
Combined hormonal contraceptives (estrogen + progestin).
Suppress ovulation and thin the endometrium, reducing menstrual flow and pain in most users Strong evidence [2]. Effective for many but not all; some people don't respond. Require ongoing prescription and carry small thrombotic risk in those with certain risk factors.
Heat (heating pads, hot water bottles).
Multiple randomized controlled trials show continuous low-level topical heat (39°C for 8 hours) is comparable to ibuprofen for acute menstrual pain relief Strong evidence [7]. Very cheap, no systemic side effects, and works for many people—often overlooked.
Cannabis.
No head-to-head randomized controlled trial data exist comparing cannabis to NSAIDs, heat, hormonal contraceptives, or placebo in people with menstrual pain. User surveys suggest perception of cannabis as comparable to or more effective than over-the-counter painkillers Weak / limited [4], but perception is not equivalent to measured efficacy. A reasonable framing: cannabis is a possible adjunct for people whose pain is inadequately controlled by NSAIDs and hormonal options, or who cannot tolerate them—not a demonstrated replacement for first-line therapy.
What we don't know
- Optimal dose, THC:CBD ratio, and route for menstrual cramps. No dose-response studies exist in this population.
- Whether cannabis addresses the underlying disease (endometriosis, adenomyosis) or only masks pain. Surveys report symptom relief; we have no data on disease progression or long-term outcomes.
- Whether tolerance develops with regular cyclical use. Does using cannabis each cycle make it less effective month to month? Unknown.
- Drug interactions with hormonal contraceptives. Both THC and CBD inhibit cytochrome P450 enzymes (CYP3A4, CYP2C19) that metabolize estrogens and progestins Weak / limited [8]. This could theoretically affect hormone levels or contraceptive efficacy, but clinical significance has not been studied in menstruating people.
- Long-term effects on menstrual cycle regularity. Heavy chronic cannabis use has been associated with anovulatory cycles in some cross-sectional studies Weak / limited, but causation is unclear and the effect size is small. We do not know whether episodic menstrual-cycle use poses similar risk.
- Whether cannabis use affects fertility or pregnancy outcomes in the context of endometriosis or other causes of dysmenorrhea. Limited data exist.
- Comparative effectiveness vs. other adjunctive approaches (magnesium supplementation, aerobic exercise, acupuncture, mindfulness) in the same population.
Risks and side effects
Acute impairment.
THC impairs cognition, coordination, reaction time, and judgment. Do not drive or operate machinery after use; impairment duration varies substantially by dose, route, individual tolerance, and food intake. Edibles typically produce longer-lasting impairment than inhalation.
Anxiety, panic, paranoia.
Higher THC doses increase anxiety risk, especially in people with a personal or family history of anxiety or psychosis. See THC Dose and Anxiety for details.
Cannabinoid hyperemesis syndrome (CHS).
Rare but serious: heavy chronic cannabis users (especially daily) can develop severe nausea, vomiting, and abdominal pain that paradoxically worsens with continued use and improves only upon cessation Strong evidence [9]. Symptoms can be mistaken for worsening menstrual or pelvic pain, delaying diagnosis. CHS typically requires weeks to months to fully resolve after stopping cannabis.
Dependence and cannabis use disorder.
Approximately 9% of adult cannabis users develop cannabis use disorder; risk is higher with daily use, early-age initiation, and higher THC potency Strong evidence [10]. Regular use can lead to tolerance, needing higher doses for the same effect.
Pregnancy.
THC crosses the placenta. Observational studies have reported associations with lower birth weight, prematurity, and neurodevelopmental concerns in offspring Weak / limited [11]. Much of the human evidence is observational and can be affected by confounding. The precautionary recommendation is to avoid cannabis if pregnant or trying to conceive.
Respiratory effects (smoking).
Smoking cannabis combusts plant material, producing irritants and potential carcinogens. Vaporizing or oral ingestion avoids combustion byproducts.
Drug interactions.
CBD and THC inhibit multiple cytochrome P450 enzymes and can raise blood levels of medications metabolized by CYP3A4 and CYP2C19 (many statins, anticonvulsants, antidepressants, immunosuppressants, etc.) Strong evidence [8]. Check with a pharmacist before combining cannabis with other drugs. See Cannabis and Polypharmacy Risks for details.
Memory and attention.
Regular heavy use is associated with persistent cognitive effects, especially in those who start young Strong evidence. Effects may improve after cessation but can take weeks to months.
Psychosis risk.
High-THC cannabis use, especially in adolescence and in people with genetic vulnerability, increases risk of psychotic disorders Strong evidence. This is rare overall but important for high-risk individuals.
Practical considerations
- If NSAIDs and heat adequately control your cramps, you do not need cannabis for this purpose. Continue with what works.
- If NSAIDs fail or cause side effects, and you are in a legal jurisdiction, cannabis is a reasonable thing to explore as an adjunct—with the understanding that evidence is mostly from surveys, not trials. Talk to a healthcare provider before starting.
- Avoid expensive vaginal suppositories. They offer no proven advantage over oral or inhaled routes and lack clinical evidence of efficacy.
- Track symptom response (pain rating, duration, functional impact) over at least 2–3 cycles to distinguish real effect from placebo or normal monthly variation.
- Do not delay or replace proper diagnosis. If your pain is severe, worsening, or new-onset, see a gynecologist or pain specialist for workup before self-treating with cannabis. Endometriosis, adenomyosis, fibroids, and cysts require diagnosis and targeted treatment.
- Be alert to cannabinoid hyperemesis syndrome, especially if you use cannabis daily. Paradoxical worsening of nausea or abdominal pain is a red flag to stop use and seek medical help.
- If you take hormonal contraceptives or other medications, discuss cannabis use with your pharmacist to screen for interactions.
- Avoid if pregnant or trying to conceive.
Sources
- Peer-reviewed Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Human Reproduction Update. 2015;21(6):762–778.
- Peer-reviewed Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database of Systematic Reviews. 2015;(7):CD001751.
- Peer-reviewed Walker OS, Holloway AC, Raha S. The role of the endocannabinoid system in female reproductive tissues. Journal of Ovarian Research. 2019;12:3.
- Peer-reviewed Sinclair J, Collett L, Abbott J, Pate DW, Sarris J, Armour M. Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms. PLoS ONE. 2021;16(10):e0258940.
- Peer-reviewed Armour M, Sinclair J, Chalmers KJ, Smith CA. Self-management strategies amongst Australian women with endometriosis: a national online survey. BMC Complementary and Alternative Medicine. 2019;19:17.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
- Peer-reviewed Akin MD, Weingand KW, Hengehold DA, et al. Continuous low-level topical heat in the treatment of dysmenorrhea. Obstetrics & Gynecology. 2001;97(3):343–349.
- Peer-reviewed Brown JD, Winterstein AG. Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use. Journal of Clinical Medicine. 2019;8(7):989.
- Peer-reviewed Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment—a systematic review. Journal of Medical Toxicology. 2017;13(1):71–87.
- Peer-reviewed Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry. 2015;72(12):1235–1242.
- Government American College of Obstetricians and Gynecologists. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstetrics & Gynecology. 2017;130(4):e205–e209.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Migraine — Observational data suggest acute benefit, but no large RCTs support cannabis as a migraine...
- Cannabis and Premenstrual Syndrome (PMS) — Survey data shows popularity; clinical trials show nothing yet proven.
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- Cannabis for Muscle Cramps — What evidence exists for cannabis in muscle cramps, spasticity, and related conditions.
- THC Dose and Anxiety — Low doses may reduce acute anxiety; higher doses increase it. Evidence is limited, risks a...
- Why Some People Don't Feel Edibles — Why oral THC fails for some users and what the evidence says.